Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus Blog Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus Streamline your SDTM mapping with Pinnacle 21 Enterprise. Discover how innovation and efficiency enhance data…CertaraAugust 13, 2025
Increasing Productivity In Pharma R&D Starts With Data Press Coverage Increasing Productivity In Pharma R&D Starts With Data This article discusses the growing volume of raw data collected during clinical research, and how…CertaraJune 25, 2025
Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis On-Demand Webinar Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis CertaraJune 11, 2025
Using SDTM Data to Produce Patient Narratives Blog Using SDTM Data to Produce Patient Narratives In this blog, we look at how medical writers can use SDTM data produced by…CertaraApril 15, 2025
Exploring Common CDISC ADaM Conformance Findings Blog Exploring Common CDISC ADaM Conformance Findings March 27, 2025 ADaM data are required by the FDA and PMDA and accepted by…CertaraMarch 27, 2025
FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format Blog FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format March 19, 2025 The CDISC Standard for the Exchange of Nonclinical Data (SEND) provides the…CertaraMarch 19, 2025
Rolling NDA and BLA Submissions: Accelerate Your Review Timeline Blog Rolling NDA and BLA Submissions: Accelerate Your Review Timeline We look at the growing regulatory trend of rolling NDA and BLA submissions to help…CertaraFebruary 3, 2025
GlobalSubmit eCTD 4.0 Webinars On-Demand Webinar GlobalSubmit eCTD 4.0 Webinars The world of electronic regulatory submissions is about to change with the introduction of eCTD…CertaraDecember 3, 2024
CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know Blog CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know December 3, 2024 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for…CertaraDecember 3, 2024
Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi Poster Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi CertaraNovember 22, 2024